These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20938532)

  • 1. Development of inositol-based antagonists for the D-myo-inositol 1,4,5-trisphosphate receptor.
    Keddie NS; Ye Y; Aslam T; Luyten T; Bello D; Garnham C; Bultynck G; Galione A; Conway SJ
    Chem Commun (Camb); 2011 Jan; 47(1):242-4. PubMed ID: 20938532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups.
    Westerduin P; Willems HA; van Boeckel CA
    Carbohydr Res; 1992 Oct; 234():131-40. PubMed ID: 1334798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
    Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
    J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-myo-inositol-1,4,5-trisphosphate and adenophostin mimics: importance of the spatial orientation of a phosphate group on the biological activity.
    Roussel F; Moitessier N; Hilly M; Chrétien F; Mauger JP; Chapleur Y
    Bioorg Med Chem; 2002 Mar; 10(3):759-68. PubMed ID: 11814866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological action of novel 4-position-modified derivatives of D-myo-inositol 1,4,5-trisphosphate.
    Bello D; Aslam T; Bultynck G; Slawin AM; Roderick HL; Bootman MD; Conway SJ
    J Org Chem; 2007 Jul; 72(15):5647-59. PubMed ID: 17585817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, acid-base behavior, and binding properties of 6-modified myo-inositol 1,4,5-tris(phosphate)s.
    Ballereau S; Guédat P; Poirier SN; Guillemette G; Spiess B; Schlewer G
    J Med Chem; 1999 Nov; 42(23):4824-35. PubMed ID: 10579845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium wave propagation in pancreatic acinar cells: functional interaction of inositol 1,4,5-trisphosphate receptors, ryanodine receptors, and mitochondria.
    Straub SV; Giovannucci DR; Yule DI
    J Gen Physiol; 2000 Oct; 116(4):547-60. PubMed ID: 11004204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both d- and l-Glucose Polyphosphates Mimic d-
    Shipton ML; Riley AM; Rossi AM; Brearley CA; Taylor CW; Potter BVL
    J Med Chem; 2020 May; 63(10):5442-5457. PubMed ID: 32286062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses of D-myo-inositol 1,4,5-trisphosphate affinity ligands.
    Tegge W; Ballou CE
    Carbohydr Res; 1992 Jun; 230(1):63-77. PubMed ID: 1324799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First derivatives of myo-inositol 1,4,6-trisphosphate modified at positions 2 and 3: structural analogues of D-myo-inositol 1,4,5-trisphosphate.
    Horne G; Mills SJ; Potter BV
    Carbohydr Res; 2004 Jan; 339(1):51-65. PubMed ID: 14659671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of D- and L-myo-inositol 2,4,5-trisphosphate and trisphosphorothioate: structural analogues of D-myo-inositol 1,4,5-trisphosphate.
    Mills SJ; Liu C; Potter BV
    Carbohydr Res; 2002 Nov; 337(20):1795-801. PubMed ID: 12431881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of metabolically stabilized cyclopentyl trisphosphate analogues of D-myo-Ins(1,4,5)P3.
    Zhang L; Huang W; Tanimura A; Morita T; Harihar S; Dewald DB; Prestwich GD
    ChemMedChem; 2007 Sep; 2(9):1281-9. PubMed ID: 17589888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.